Recently Updated
- 11/01/2012
- Misoprostol for Treatment of Incomplete Abortion: A Training Guide
- 10/01/2012
- Pre-eclampsia Program Brief
- 09/01/2012
- List of Mifepristone Approvals
- 09/01/2012
- Map of Mifepristone Approvals
- 06/01/2012
- Clinical Studies List
Resources by Author
Author Selected: Winikoff, Beverly (see all authors)
Misoprostol and Teratogenicity: Reviewing the Evidence
Misoprostol for Women’s Health
Mifepristone medical abortion in Albania
Regimens of misoprostol with mifepristone for early medical abortion
Clostridium sordellii infection in medical abortion
Misoprostol for uterine evacuation in induced abortion and pregnancy failure
Are two doses of misoprostol after mifepristone for early abortion better than one?
Alternatives to mifepristone for early medical abortion
Mifepristone for late first trimester abortion
Can mifepristone medical abortion be simplified?
Methotrexate compared to misoprostol alone for early medical abortion
Assessment of pregnancy duration among termination of pregnancy clients in South Africa
The supreme court and the partial-birth abortion ban act of 2003
Misoprostol for incomplete abortion in Mozambique
Misoprostol for incomplete abortion in Tanzania
Misoprostol for incomplete abortion in Burkina Faso
Treatment of postpartum hemorrhage with misoprostol
Prevention of postpartum hemorrhage with misoprostol
Treatment of incomplete abortion and miscarriage with misoprostol
Misoprostol to treat missed abortion in the first trimester
Supervision for use of mifepristone medical abortion
Integrating medical abortion into safe abortion services in South Africa
Comment on Misoprostol impairs female reproductive tract innate immunity against C. sordellii
Two distinct oral routes of misoprostol in mifepristone medical abortion
Sublingual misoprostol after mifepristone
Non-physician clinicians can safely provide first trimester medical abortion
Sublingual misoprostol for incomplete abortion
Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone
Increasing women’s choices in medical abortion in Turkey
Knowledge, attitudes, and practice of abortion among women and doctors in Armenia
Acceptability and feasibility of medical abortion in Nepal
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 1/2
Sublingual misoprostol for treatment of postpartum hemorrhage Trial 2/2
Alternatives to Routine Follow-Up for Early Medical Abortion
High fever following postpartum administration of sublingual misoprostol
What measured blood loss tells us about postpartum bleeding
Misoprostol as adjunct treatment for treatment of postpartum haemorrhage
Unsafe Abortion and Strategies to Reduce its Impact on Women’s Lives
Sublingual misoprostol vs. MVA for the treatment of incomplete abortion in Egypt
Self-induction of abortion among women in the United States
Buccal vs. sublingual misoprostol after mifepristone for medical abortion
Oral misoprostol as an alternative to surgical management for incomplete abortion in Ghana
Ultrasound for eligibility assessment for medical abortion
Introduction and provision of medical abortion: A tale of two countries
Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone
Review of the Literature on Patient Satisfaction with Early Medical Abortion
Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion
Treatment approaches for preeclampsia in low-resource settings
Oral Misoprostol for the Management of Incomplete Abortion in Ecuador
Facility and personnel factors influencing magnesium sulfate use for eclampsia and pre-eclampsia
Misoprostol for postpartum hemorrhage: Moving from evidence to practice
Two doses of buccal misoprostol following mifepristone
Misoprostol for the prevention and treatment of postpartum hemorrhage
Comparison of regimens for home-based early medical abortion in Tunisia and Vietnam
First-trimester medical abortion with mifepristone 200 mg and misoprostol: A systematic review
At-home semi-quantitative pregnancy tests as replacement for clinical follow-up of medical abortion
Use of Medicines Changing the Face of Abortion
Clinic-level introduction of medical abortion in Vietnam
Misoprostol as first-line treatment for incomplete abortion in Nigeria
Misoprostol for the management of postpartum bleeding: A new approach
Sublingual Misoprostol for the Treatment of Postpartum Hemorrhage
Misoprostol for Treatment of Incomplete Abortion: A Training Guide
Incomplete abortion in five sub-Saharan African countries
Acceptability of home use of mifepristone for medical abortion